Skip to content

THERIK

Active
Private limited companyfounded 201610 yrs activeStevoortse kiezel 280, 3512 Hasselt, BelgiumKBO/BCE: BE 0651.630.657

THERIK has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €175k and a net result of €25k. Equity is growing by ~25% per year across the filed fiscal years. Its solvency ranks better than 61% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
93 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability82=
Solvency99▲+3
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €16k at 30 days acceptable
Liquidity ample (current ratio 2.74 against 2.17 in 2024; short-term debt: 25.5% and cash: 66.3% of total assets), and 26% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
74%
Return on assets
10.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
24 d early
2024
17 d early
2023
26 d early
2022
24 d early
2021
30 d early
2020
24 d early
2019
23 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€175k▲ 16.8%
2024 · €149k
2018: €25k 2019: €45k 2020: €56k 2021: €78k 2022: €101k 2023: €126k 2024: €149k
2018 → 2025
Total assets
€236k▲ 11.8%
2024 · €211k
2018: €33k 2019: €135k 2020: €147k 2021: €157k 2022: €177k 2023: €195k 2024: €211k
2018 → 2025
Net result
€25k▲ 8.3%
2024 · €23k
2018: €19k 2019: €20k 2020: €11k 2021: €22k 2022: €24k 2023: €25k 2024: €23k
2018 → 2025
Working capital
€105k▲ 48.0%
2024 · €71k
2018: €18k 2019: €-64k 2020: €-47k 2021: €-18k 2022: €15k 2023: €42k 2024: €71k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€78k-€101k▲ 30.9%€126k▲ 24.4%€149k▲ 18.4%€175k▲ 16.8%
Operating result€31k-€35k▲ 11.8%€35k▲ 1.7%€32k▼ 7.8%€35k▲ 8.7%
Net result€22k-€24k▲ 9.8%€25k▲ 3.2%€23k▼ 6.2%€25k▲ 8.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€10k€20k€30k€40kOperating result 2021: €31k€31kNet result 2021: €22k€22kOperating result 2022: €35k€35kNet result 2022: €24k€24kOperating result 2023: €35k€35kNet result 2023: €25k€25kOperating result 2024: €32k€32kNet result 2024: €23k€23kOperating result 2025: €35k€35kNet result 2025: €25k€25k20212022202320242025
The operating result recovers in 2025; 2025 is 9% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €236k
Fixed assets €71k▼ 11.2%
Current assets €165k▲ 25.9%
Equity and liabilities €236k
Equity €175k▲ 16.8%
Provisions €903▼ 20.1%
Debt €61k=
The debt ratio falls from 28.7% to 25.7%. Equity is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€45k
2024 · €42k
Cash flow
€35k
2024 · €33k
Solvency
74.0%
2024 · 70.8%
Current ratio
2.74
2024 · 2.17
Quick ratio
2.73
2024 · 2.17
Debt / equity
0.35
2024 · 0.41
ROE
14.4%
2024 · 15.5%
ROA
10.7%
2024 · 11.0%
Interest coverage
164.66
2024 · 131.62
Debt
€61k=
2024 · €61k
Debt ≤ 1 year
€60k=
2024 · €60k
Income taxes
€10k
2024 · €8k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€211k€236k
Fixed assets21/28€80k€71k
Tangible fixed assets22/27€80k€71k
Land and buildings22€75k€68k
Plant, machinery and equipment23-€884
Furniture and vehicles24€6k€3k
Current assets29/58€131k€165k
Stocks and contracts in progress3€510€612
Stocks30/36€510€612
Amounts receivable within one year40/41€7k€5k
Trade receivables40€7k€5k
Other amounts receivable41€256-
Cash at bank and in hand54/58€121k€157k
Deferred charges and accrued income490/1€2k€3k
Equity and liabilities
Total equity and liabilities10/49€211k€236k
Equity10/15€149k€175k
Contributions10/11€6k€6k=
Reserves13€107k€132k
Tax-exempt reserves132€3k€3k
Distributable reserves133€103k€129k
Profit (loss) carried forward14€37k€37k=
Provisions and deferred taxes16€1k€903
Deferred taxes168€1k€903
Amounts payable17/49€61k€61k=
Amounts payable within one year42/48€60k€60k=
Trade debts44€196€459
Suppliers440/4€196€459
Taxes, remuneration and social security45€71€3k
Taxes450/3€71€3k
Remuneration and social security454/9-€200
Other amounts payable47/48€60k€56k
Accrued charges and deferred income492/3€379€395
Income statement Code20242025
Non-recurring operating income76A€7k-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€10k
Other operating charges640/8€1k€700
Gross operating margin9900€43k€46k
Operating profit (loss)9901€32k€35k
Financial income75/76B€2€2
Recurring financial income75€2€2
Financial charges65/66B€319€275
Recurring financial charges65€319€275
Profit (loss) for the period before taxes9903€32k€35k
Transfer from deferred taxes780€147€227
Transfer to deferred taxes680€1k-
Income taxes67/77€8k€10k
Profit (loss) for the period9904€23k€25k
Transfer from tax-exempt reserves789€440€680
Transfer to tax-exempt reserves689€4k-
Profit (loss) for the period to be appropriated9905€20k€26k
Appropriation of the result
Profit (loss) to be appropriated9906€56k€62k
Profit (loss) brought forward from the previous period14P€37k€37k=
Transfer to equity691/2€20k€26k
To other reserves6921€20k€26k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
07-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Highest result since 2018net €25k ▲8.3%
Operating result €35k, net result €25k, both a record.
31-12
Financial Equity above €150kEq €175k ▲16.8%
8 profitable years in a row build equity to €175k.
14-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
05-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
07-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Equity above €100kEq €101k ▲30.9%
5 profitable years in a row build equity to €101k.
01-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
07-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Weakest financial yearnet €11k ▼44.6%
Net result drops to €11k, the lowest in the series; recovery starts the following year.
08-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
15-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
29-06
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hasselt · 1 establishment unit since 2016
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Stevoortse kiezel 2803512 Hasselt
Ground area
1,106 m²
Building footprint
218 m²
Volume, LiDAR
1,171 m³
Parcel 71055B0451/00X011, Flanders · tallest building 7.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
THERIK BVBA
Stevoortse kiezel 280, 3512 HasseltGeneral medical practice
since 20162.252.718.003
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71055B0451/00X011 Flanders 1,106 m² 1 · 217 m² 7.9 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2022 to 2023 · 2 entries · 345 EUR awarded · 345 EUR paid
Year Entries awardedpaid
2023 1 165 EUR165 EUR
2022 1 180 EUR180 EUR
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
2 entries · 345 EUR · 345 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 12,689 companies in sector 86951 we hold annual accounts for 2,142. 1,675 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded05-04-2016
Fiscal year end31-12
Activities, NACEBEL
86905Human health activities
86951Physiotherapy
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers

Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.